Previous projects

Effectiveness of a smoking cessation intervention in patients with mental disorders
People with mental disorders are more likely to smoke and the more severe the disorder, the greater the tobacco consumption. In Catalonia, 74.4% of hospitalized patients with mental disorders smoke, tripling tobacco consumption in the general population (27.1%).
In the last decade, some cost-effective measures have been implemented to control smoking with the aim of reducing tobacco-related diseases and associated mortality in this vulnerable group. These measures include:
– Smoke-free space policies;
– Treatment to quit smoking, including psychological support and pharmacological therapy and
– Community measures of sustained support.
In our country, Law 42/2010 prohibits smoking in the interior and exterior spaces of acute hospitals, including psychiatric units. Patients with mental illness admitted have the opportunity to receive professional help and remain abstinent during their hospital stay due to the need to comply with regulations. However, once discharged, the type of community support for quitting smoking aimed at these patients is insufficient.
The QUIT_Mental project proposes to provide support to quit smoking to patients with mental disorders who have been admitted to acute hospitals after discharge from hospital through expert telephone support provided by nurses from 061 CatSalut Respon.
To evaluate the effectiveness of a telephone intervention to quit smoking using an intensive motivational approach.
Pragmatic and community-based randomized clinical trial. Participants who meet the inclusion and exclusion criteria will be randomized to the Intervention Group and the Control Group with a 2:1 allocation. A total of five high-tech hospitals in Barcelona city are participating in the study, which will recruit a total of 1,002 patients.
The main dependent variable will be abstinence from tobacco consumption, self-reported and verified through salivary cotinine. Other study variables are the number of quit attempts, maximum abstinence time, level of motivation and self-efficacy.
2016-2018. Currently in the design phase for the launch of the study.
PI15/00875 (€74,415, in three years) from the Health Research Fund of the Carlos III Institute of Health (Fondo de Desarrollo Regional Europeo, FEDER).
Cristina Martínez (Principal Inv., ICO-IDIBELL)
Esteve Fernández (Principal Inv., ICO-IDIBELL)
Laura Allaustre (061 CatSalut Respon)
Montse Ballbè (ICO)
Roser Blanc (061 CatSalut Respon)
Eugeni Bruguera (Vall d’Hebron University)
Xavier Escalda (061 CatSalut Respon)
Marta Enriquez (ICO-IDIBELL)
Ariadna Feliu (UCT ICO-IDIBELL)
Joseph Guydish (UCSF)
Rosa Hernandez (H. Bellvitge)
Silvia Mondón (H. Clinic)
Cristina Pinet (Saint Paul’s Parish)
Nuria Quirós (ICO)
Antonia Raich (Althaia)
Susana Subira (University of Barcelona)
Josep Maria Suelves (Department of Health)
Núria Torres (061 CatSalut Respon)
Jordi Vicens (University of Barcelona)